pa-56-35-1257: Laboratories approved to perform blood lead and/or erythrocyte protoporphyrin determinations under The Clinical Laboratory Act (Part II)

Summary

The following laboratories are licensed in accordance with The Clinical Laboratory Act (35 P.S. §§ 2151 2165) and are currently approved under 28 Pa. Code§ 5.50 (relating to approval to provide special analytical services) to perform analyses of blood for lead or erythrocyte protoporphyrin content. This approval is based on demonstrated proficiency in periodic evaluations conducted by the Bureau of Laboratories of the Department of Health (Department). Lead poisoning is reportable. Approved laboratories that offer blood lead testing services are required to inform the Department of actual or possible incidents of this condition in accordance with 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning). These regulations specify the following requirements for reporting by clinical laboratories: (1) A clinical laboratory shall report all blood lead test results on both venous and capillary specimens for persons under 16 years of age to the Department's Childhood Lead Poisoning Prevention Program, Division of Maternal and Child Health, Bureau of Family Health. (2) A clinical laboratory shall report an elevated blood lead level in a person 16 years of age or older to the Department's Division of Environmental Health Epidemiology, Bureau of Epidemiology or to other locations as designated by the Department. Under 28 Pa. Code 27.34(a)(2), an elevated blood lead level is defined by the National Institute for Occupational Safety and Health (NIOSH). As of 2015, NIOSH...

The agency’s own summary, as published.